Unibail-Rodamco-Westfield (“URW”) announces tender offer results

Paris, Amsterdam, December 3, 2020

Press release

Unibail-Rodamco-Westfield (“URW”) announces tender offer results

Further to the announcement on November 25, 2020, of the successful €2 Bn bond issuance and the launch of the concurrent tender offer, URW today announces the results of its tender offer, which will enable the Group to repurchase bonds with a total nominal amount of €544.9 Mn (19.56% of the outstanding amount) as detailed below:

ISIN Issue Date Maturity Coupon Outstanding Amount Tendered Amount Outstanding Amount after tender offer
XS0894202968 25/02/2013 25/02/2021 2.375% €418,380,000   €31,150,000 €387,230,000
FR0013332970 15/05/2018 14/05/2021 0.125% €800,000,000   €314,500,000 €485,500,000
XS1121177338 15/10/2014 17/10/2022 1.375% €318,515,000   €61,174,000 €257,341,000
XS0942388462 12/06/2013 12/06/2023 2.500% €498,792,000   €31,782,000 €467,010,000
XS1038708522 26/02/2014 26/02/2024 2.500% €750,000,000   €106,252,000 €643,748,000

The tender offer will be funded from the net proceeds of the November 2020 bond issuance, and is part of the Group’s active debt management strategy.

URW accepted all tenders and the settlement will take place on December 4, 2020.

For further information, please contact:

Investor Relations 

Samuel Warwood
Maarten Otte 
+33 1 76 77 58 02 
[email protected]

Media Relations 

Céline van Steenbrugghe
+33 6 71 89 73 08
[email protected]

About Unibail-Rodamco-Westfield

Unibail-Rodamco-Westfield is the premier global developer and operator of Flagship Destinations, with a portfolio valued at €58.3 Bn as at September 30, 2020, of which 86% in retail, 7% in offices, 5% in convention & exhibition venues and 2% in services. Currently, the Group owns and operates 89 shopping centres, including 55 Flagships in the most dynamic cities in Europe and the United States. Its centres welcome 1.2 billion visits per year. Present on two continents and in 12 countries, Unibail-Rodamco-Westfield provides a unique platform for retailers and brand events and offers an exceptional and constantly renewed experience for customers.
With the support of its 3,400 professionals and an unparalleled track-record and know-how, Unibail-Rodamco-Westfield is ideally positioned to generate superior value and develop world-class projects.
Unibail-Rodamco-Westfield distinguishes itself by its Better Places 2030 agenda, that sets its ambition to create better places that respect the highest environmental standards and contribute to better cities.
Unibail-Rodamco-Westfield stapled shares are listed on Euronext Amsterdam and Euronext Paris (Euronext ticker: URW), with a secondary listing in Australia through Chess Depositary Interests. The Group benefits from an BBB+ rating from Standard & Poor’s and from a Baa1 rating from Moody’s.

For more information, please visit www.urw.com
Visit our Media Library at https://mediacentre.urw.com
Follow the Group updates on Twitter @urw_group, Linkedin @Unibail-Rodamco-Westfield and Instagram @urw_group

Attachment



ESI Contributes to Nissan’s Breakthrough in Carbon Fiber Parts Production for Safer and Lighter Vehicles

ESI Contributes to Nissan’s Breakthrough in Carbon Fiber Parts Production for Safer and Lighter Vehicles

PARIS–(BUSINESS WIRE)–ESI Group (Paris:ESI), global player in Virtual Prototyping software and services for industry, supports Nissan Motor Co in its production process that speeds up the development of car parts made from carbon fiber reinforced plastics (CFRP). Light yet extremely strong, this material will be used to make safer and more fuel-efficient cars.

Safety, comfort and autonomy are key outcomes for consumers. To face this situation, automakers continuously innovate in different fields such as lightweight to help them achieve their expected results. For this purpose, the use of new materials can be key. Commonly used in other industries such as Aerospace and with promising capabilities, Carbon Fiber Reinforced Plastics (CFRP) were too time-consuming and too expensive to industrialize for the Automotive sector.We have always considered CFRP as a material for future generations of cars. But when it comes to reality, CFRP can be used only for limited models and appears to be more challenging for mass market production. Indeed, costs are high, and complex designs are required to shape CFRP. The challenge was to industrialize its production process in order to reduce costs and development time.” explains Hideyuki Sakamoto, EVP of Nissan Motor Co.

ESI Group has been supporting Nissan’s CFRP challenge since 2015 in the evolution of its industrial product design and manufacturing methodologies for various vehicle models. The partnership was strengthened in 2018 with the CFRP mass production project.

To overcome the difficulty in shaping CFRP parts, Nissan’s engineers, helped by ESI’s solution, found a new approach: the process of Compression Resin Transfer Molding (C-RTM). The existing method involves forming carbon fiber into the right shape and setting it in a die with a slight gap between the upper die and the carbon fibers. Resin is then injected into the fiber and left to harden. Nissan’s engineers developed techniques to accurately simulate the permeability of the resin in carbon fiber, while visualizing resin flow behavior in a die using an in-die temperature sensor and a transparent die. The result of the successful simulation was a high-quality component with shorter development time. Using Virtual Prototype of the product, Nissan succeeded: a high-quality component with a development time reduced by 50% and reduced by 80% of single molding.

“We are proud of the support we have brought Nissan over the years and throughout this project. We have helped them succeed in the full development process, from the design to the manufacturing of mass-produced CFRP parts, thus enabling their breakthrough for lighter and safer vehicles. Nissan’s success embodies our mission to enable industrial players to commit to outcomes. With our Smart Manufacturing solution and our historical expertise in materials, we helped them reach their ambitions,” concludes Cristel de Rouvray, CEO of ESI Group.

About ESI Group

Founded in 1973, ESI Group is a leading innovator in Virtual Prototyping solutions and a global enabler of industrial transformation. Thanks to the company’s unique know-how in the physics of materials, it has developed and refined, over the last 45 years, advanced simulation capabilities. Having identified gaps in the traditional approach to Product Lifecycle Management (PLM), ESI has introduced a holistic methodology centered on industrial productivity and product performance throughout its entire lifecycle, i.e. Product Performance Lifecycle™, from engineering to manufacturing and in operation. Present in more than 20 countries, and in major industrial sectors, ESI employs 1200 high level specialists. In 2019, its turnover was 146M€. ESI is headquartered in France and is listed on compartment B of Euronext Paris. For further information, go to www.esi-group.com.

ESI Group Press Relationship – Shan

Florence Barré

[email protected]
+33 1 49 78 28 28

Lola Gozlan

[email protected]
+ 33 6 24 76 83 40

KEYWORDS: France Europe

INDUSTRY KEYWORDS: Technology Automotive Engineering Manufacturing Other Automotive Software Performance & Special Interest Electronic Design Automation Data Management

MEDIA:

Jazz Pharmaceuticals and PharmaMar Announce Results of ATLANTIS Phase 3 Study Evaluating Zepzelca™ in Combination with Doxorubicin for Patients with Small Cell Lung Cancer Following One Prior Platinum-containing Line

PR Newswire

DUBLIN, Dec. 3, 2020 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ), along with its partner, PharmaMar (MSE: PHM), today announce results from the ATLANTIS Phase 3 multicenter, randomized, controlled study evaluating Zepzelca™ (lurbinectedin) in combination with doxorubicin versus physician’s choice of topotecan or cyclophosphamide/doxorubicin/vincristine (CAV) for adult patients with small cell lung cancer (SCLC) whose disease progressed following one prior platinum-containing line. Patients received lurbinectedin at 2.0mg/m2 in the combination arm, which is lower than the FDA approved dose of Zepzelca at 3.2mg/m2.

The study did not meet the pre-specified criteria of significance for the primary endpoint of overall survival (OS) in the intent-to-treat (ITT) population comparing lurbinectedin in combination with doxorubicin to the control arm, though there was no adverse effect on OS with the experimental arm. Based on the study design, no additional hypotheses were formally tested. Importantly, key secondary and subgroup analyses favored the lurbinectedin combination arm. Lurbinectedin monotherapy was not tested in ATLANTIS.

The safety data in this study was consistent with the known safety profile of lurbinectedin monotherapy with no new safety signals observed. The experimental arm showed favorable safety and tolerability with regard to Grade-3 or greater drug related adverse events (AEs), deaths due to AEs, hematologic toxicity, dose reductions and treatment discontinuations due to AEs, compared to the control arm.

“Bringing Zepzelca to the U.S. market earlier this year alongside our partner, PharmaMar, was an important advance for adults with metastatic SCLC, an aggressive disease with a historically poor prognosis,” said Robert Iannone M.D., M.S.C.E., executive vice president, research and development of Jazz Pharmaceuticals. “While the combination of lurbinectedin and doxorubicin did not achieve the primary endpoint in this study, the overall results support the activity and tolerability of lurbinectedin in this line of therapy. We look forward to the further development of lurbinectedin in SCLC and other tumors, both as monotherapy and in combination.”

“We remain committed to improving outcomes for patients with metastatic small cell lung cancer where there is a high unmet medical need; we continue to evaluate the safety and efficacy of lurbinectedin in SCLC and other tumors. The drug’s activity in this disease and setting has been reinforced in this trial,” said Luis Mora, managing director, oncology business unit, PharmaMar. “We extend our gratitude to the patients, physicians and their staff as well as caregivers who participated in this clinical study.”

“Historically, patients with relapsed SCLC often face difficult odds due to the aggressive nature of the disease and they have had very limited treatment options. As a physician treating patients with SCLC, I’m confident in lurbinectedin as an effective new option in this traditionally challenging therapeutic area,” Alberto Chiappori, MD, senior member of oncology and medicine for the Department of Thoracic Oncology at the H. Lee Moffitt Cancer Center and Research Institute and ATLANTIS Phase 3 study investigator.

Results will be discussed with the appropriate regulatory authorities and will be presented at a future medical meeting.

The U.S. Food and Drug Administration (FDA) approved Zepzelca under accelerated approval in June 2020 for the treatment of adult patients with metastatic SCLC with disease progression on or after platinum-based chemotherapy. The approval is based on ORR and duration of response demonstrated in an open-label, monotherapy clinical study. The companies will provide the ATLANTIS data to FDA and look forward to working with the agency to determine the confirmatory data that is needed for full approval.

ATLANTIS Phase 3 Study Design
The ATLANTIS Phase 3 study enrolled 613 patients at 154 sites primarily in the U.S., Canada, Latin America and Western Europe from September 2016 through July 2018. Patients enrolled were ≥18 years with histologically or cytologically confirmed diagnosis of limited or extensive stage SCLC, had failed one prior platinum-containing regimen, and had a chemotherapy-free interval (CTFI, time from the last dose of first-line chemotherapy to the occurrence of progressive disease) ≥ 30 days. Patient inclusion criteria included small-cell carcinoma of unknown primary site with or without neuroendocrine features confirmed in histology test(s) performed on metastatic lesion(s) are eligible, if Ki-67/MIB-1 is expressed in >50 percent of tumor cells.

In the trial, patients were randomized in a 1:1 ratio to receive lurbinectedin in combination with doxorubicin or physician’s choice of topotecan OR cyclophosphamide/doxor ubicin/vincristine (CAV). The primary endpoint was overall survival. The secondary endpoints were 1) the difference in OS for patients in the lurbinectedin/doxorubicin arm compared to patients treated with CAV; 2) OS and progression free survival (PFS) in patients with or without CNS involvement; 3) PFS by independent review committee (IRC); 4) antitumor activity defined by objective response rate (ORR) per IRC; and 5) duration of response per IRC.

The study sample was stratified by the following factors: CTFI (chemotherapy free interval); ECOG performance status (0 vs. 1-2); CNS involvement vs. no involvement; prior immunotherapy against either programmed cell death protein-1 (PD-1) or programmed death ligand-1 (PD-L1); and investigator preference of topotecan and CAV.

About Zepzelca™ (lurbinectedin)

Zepzelca is an alkylating drug that binds guanine residues within DNA. This triggers a cascade of events that can affect the activity of DNA binding proteins, including some transcription factors, and DNA repair pathways, resulting in disruption of the cell cycle and eventual cell death.1

Zepzelca for injection 4 mg is a prescription medicine used to treat adults with a kind of lung cancer called small cell lung cancer that has spread to other parts of the body (metastatic) and who have received treatment with chemotherapy that contains platinum, and it did not work or is no longer working. Zepzelca is approved based on response rate and how long the response lasted. Additional studies will further evaluate the benefit of Zepzelca for this use.

Important Safety Information

Before receiving ZEPZELCA, tell your healthcare provider about all of your medical conditions, including if you:

  • have liver or kidney problems.
  • are pregnant or plan to become pregnant. ZEPZELCA can harm your unborn baby.
    Females who are able to become pregnant:
    • Your healthcare provider should do a pregnancy test before you start treatment with ZEPZELCA.
    • You should use effective birth control (contraception) during treatment with and for 6 months after your final dose of ZEPZELCA.
    • Tell your healthcare provider right away if you become pregnant or think that you are pregnant during treatment with ZEPZELCA.

Males with female partners who are able to become pregnant should use effective birth control during treatment with and for 4 months after your final dose of ZEPZELCA.

  • are breastfeeding or plan to breastfeed. It is not known if ZEPZELCA passes into your breastmilk. Do not breastfeed during treatment with ZEPZELCA and for 2 weeks after your final dose of ZEPZELCA. Talk to your healthcare provider about the best way to feed your baby during treatment with ZEPZELCA.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Certain other medicines may affect how ZEPZELCA works.

What should I avoid while using ZEPZELCA?

Avoid eating or drinking grapefruit, or products that contain grapefruit juice during treatment with ZEPZELCA.

ZEPZELCA can cause serious side effects, including:

  • Low blood cell counts. Low blood counts including low neutrophil counts (neutropenia) and low platelet counts (thrombocytopenia) are common with ZEPZELCA, and can also be severe. Some people with low white blood cell counts may get fever, or an infection throughout the body (sepsis), that can cause death. Your healthcare provider should do blood tests before you receive each treatment with ZEPZELCA to check your blood cell counts.
    Tell your healthcare provider right away if you develop:
    • fever or any other signs of infection
    • unusual bruising or bleeding
    • tiredness
    • pale colored skin
  • Liver problems. Increased liver function tests are common with ZEPZELCA, and can also be severe. Your healthcare provider should do blood tests to check your liver function before you start and during treatment with ZEPZELCA.
    Tell your healthcare provider right away if you develop symptoms of liver problems including:
    • loss of appetite 
    • nausea or vomiting 
    • pain on the right side of your stomach area (abdomen)

Your healthcare provider may temporarily stop treatment, lower your dose, or permanently stop ZEPZELCA if you develop low blood cell counts or liver problems during treatment with ZEPZELCA.

The most common side effects of ZEPZELCA include:

  • tiredness
  • low white and red blood cell counts
  • increased kidney function blood test (creatinine)
  • increased liver function blood tests
  • increased blood sugar (glucose)
  • nausea
  • decreased appetite
  • muscle and joint (musculoskeletal) pain
  • low level of albumin in the blood
  • constipation
  • trouble breathing
  • low levels of sodium and magnesium in the blood
  • vomiting
  • cough
  • diarrhea

These are not all of the possible side effects of ZEPZELCA.

Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report side effects to Jazz Pharmaceuticals at 1-800-520-5568.

More information about Zepzelca, including Full Prescribing Information and Patient Information, is available here.

ZEPZELCA is a trademark of PharmaMar, S.A. used by Jazz Pharmaceuticals under license.


About Jazz Pharmaceuticals

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharmaceutical company dedicated to developing and commercializing life-changing medicines that transform the lives of patients with serious diseases – often with limited or no options.  We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in key therapeutic areas. Our focus is in neuroscience, including sleep and movement disorders, and in oncology, including hematologic malignancies and solid tumors. We actively explore new options for patients including novel compounds, small molecule advancements, biologics and innovative delivery technologies. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in more than 90 countries. For more information, please visit www.jazzpharmaceuticals.com and follow @JazzPharma on Twitter.

About PharmaMar
Headquartered in Madrid, PharmaMar is a biopharmaceutical company, focused on oncology and committed to research and development which takes its inspiration from the sea to discover molecules with antitumor activity. It is a company that seeks innovative products to provide healthcare professionals with new tools to treat cancer. Its commitment to patients and to research has made it one of the world leaders in the discovery of antitumor drugs of marine origin.

PharmaMar has a pipeline of drug candidates and a robust R&D oncology program. It develops and commercializes Yondelis® in Europe and has other clinical-stage programs under development for several types of solid cancers: lurbinectedin (PM1183), PM184 and PM14. With subsidiaries in Germany, Italy, France, Switzerland, Belgium, Austria and the United States. PharmaMar wholly owns other companies: GENOMICA, a molecular diagnostics company; Sylentis, dedicated to researching therapeutic applications of gene silencing (RNAi). To learn more about PharmaMar, please visit us at www.pharmamar.com.

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995
This press release contains forward-looking statements, including, but not limited to, statements related to engaging with the appropriate regulatory agencies, including providing the ATLANTIS data to FDA and working with the agency to determine the confirmatory data that is needed for full approval of lurbinectedin; the further development of lurbinectedin in SCLC and other tumors, both as monotherapy and in combination; the company’s belief that the overall results of ATLANTIS support the activity and tolerability of lurbinectedin in adults with metastatic SCLC; and other statements that are not historical facts. These forward-looking statements are based on Jazz Pharmaceuticals’ current plans, objectives, estimates, expectations and intentions and inherently involve significant risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks and uncertainties associated with pharmaceutical product development, including clinical data read-outs; the time-consuming and uncertain regulatory approval process, including the risk that FDA may not grant full approval to lurbinectedin; and other risks and uncertainties affecting Jazz Pharmaceuticals and its development programs, including those described from time to time under the caption “Risk Factors” and elsewhere in Jazz Pharmaceuticals plc’s Securities and Exchange Commission filings and reports (Commission File No. 001-33500), including Jazz Pharmaceuticals’ Quarterly Report on Form 10-Q for the quarter ended September 30, 2020 and future filings and reports by Jazz Pharmaceuticals. Other risks and uncertainties of which Jazz Pharmaceuticals is not currently aware may also affect Jazz Pharmaceuticals’ forward-looking statements and may cause actual results and the timing of events to differ materially from those anticipated. The forward-looking statements herein are made only as of the date hereof or as of the dates indicated in the forward-looking statements, even if they are subsequently made available by Jazz Pharmaceuticals on its website or otherwise. Jazz Pharmaceuticals undertakes no obligation to update or supplement any forward-looking statements to reflect actual results, new information, future events, changes in its expectations or other circumstances that exist after the date as of which the forward-looking statements were made.

References:
1. ZEPZELCA (lurbinectedin) Prescribing Information. Palo Alto, CA: Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals Media and Investor Relations Contact

Media Contact:

Jacqueline Kirby, Vice President, Corporate Affairs & Government Relations
Ireland +353 1 697 2141 U.S. +1 215 867 4910

Investor Contact:

Kathee Littrell, Vice President, Investor Relations
Ireland +353 1 634 7887 U.S. +1 650 496 2717

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/jazz-pharmaceuticals-and-pharmamar-announce-results-of-atlantis-phase-3-study-evaluating-zepzelca-in-combination-with-doxorubicin-for-patients-with-small-cell-lung-cancer-following-one-prior-platinum-containing-line-301185390.html

SOURCE Jazz Pharmaceuticals plc

Jumia Announces the Completion of its At The Market Offering

Jumia Announces the Completion of its At The Market Offering

BERLIN–(BUSINESS WIRE)–Jumia Technologies AG (“Jumia”), the leading pan-African e-commerce platform, announced that it has completed its “at the market” offering. All 7,969,984 ADSs offered by Jumia have been sold at an average price of $30.51 per ADS, generating aggregate gross process of $243.2 million. Proceeds, net of commissions and expenses, are expected to be $231.4 million. Jumia intends to use the net proceeds from this offering for general corporate purposes.

On November 30, 2020, Jumia filed a prospectus supplement with the Securities and Exchange Commission for the sale of 7,969,984 ADSs through an “at the market” offering with Citigroup Global Markets Inc. as Jumia’s agent.

About Jumia

Jumia is the leading pan-African e-commerce platform. Jumia’s platform consists of its marketplace, which connects sellers with consumers, its logistics service, which enables the shipment and delivery of packages from sellers to consumers, and its payment service, which facilitates transactions among participants active on our platform in selected markets.

Forward Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this release include, but are not limited to, statements concerning the use of proceeds from the offering. Risks and uncertainties that could cause actual outcomes and results to differ materially from those contemplated by the forward-looking statements are included under the caption “Risk Factors” in Jumia’s registration statement on Form F-3. Forward-looking statements speak only as of the date the statements are made and are based on information available to Jumia at the time those statements are made and / or management’s good faith belief as of that time with respect to future events. Jumia assumes no obligation to update forward-looking statements to reflect events or circumstances after the date that they were made, except as required by law.

Safae Damir

Head of Investor Relations

[email protected]

Abdesslam Benzitouni

Head of PR and Communications

[email protected]

KEYWORDS: Germany Europe

INDUSTRY KEYWORDS: Technology Retail Online Retail Internet

MEDIA:

Logo
Logo

ROYAL DUTCH SHELL PLC THIRD QUARTER 2020 EURO AND GBP EQUIVALENT DIVIDEND PAYMENTS

The Hague, December 3, 2020 – The Board of Royal Dutch Shell plc (“RDS”) today announced the pounds sterling and euro equivalent dividend payments in respect of the third quarter 2020 interim dividend, which was announced on October 29, 2020 at US$0.1665 per A ordinary share (“A Share”) and B ordinary share (“B Share”).

Dividends on A Shares will be paid, by default, in euros at the rate of €0.1386 per A Share. Holders of A Shares who have validly submitted US dollars or pounds sterling currency elections by November 27, 2020 will be entitled to a dividend of US$0.1665 or 12.48p per A Share, respectively.

Dividends on B Shares will be paid, by default, in pounds sterling at the rate of 12.48p per B Share. Holders of B Shares who have validly submitted US dollars or euros currency elections by November 27, 2020 will be entitled to a dividend of US$0.1665 or €0.1386 per B Share, respectively.

Euro and pounds sterling dividends payable in cash have been converted from US dollars based on an average of market exchange rates over the three dealing days from 30 November to 2 December 2020.

This dividend will be payable on December 16, 2020 to those members whose names were on the Register of Members on November 13, 2020.

Taxation – cash dividend

Cash dividends on A Shares will be subject to the deduction of Dutch dividend withholding tax at the rate of 15%, which may be reduced in certain circumstances. Non-Dutch resident shareholders, depending on their particular circumstances, may be entitled to a full or partial refund of Dutch dividend withholding tax.

If you are uncertain as to the tax treatment of any dividends you should consult your tax advisor.

Note

A different currency election date may apply to shareholders holding shares in a securities account with a bank or financial institution ultimately holding through Euroclear Nederland. This may also apply to other shareholders who do not hold their shares either directly on the Register of Members or in the corporate sponsored nominee arrangement. Shareholders can contact their broker, financial intermediary, bank or financial institution for the election deadline that applies.

Royal Dutch Shell plc

ENQUIRIES:

Media:  
International +44 (0) 207 934 5550
Americas +1 832 337 4355

CAUTIONARY NOTE

The companies in which Royal Dutch Shell plc directly and indirectly owns investments are separate legal entities. In this announcement “Shell”, “Shell Group” and “Royal Dutch Shell” are sometimes used for convenience where references are made to Royal Dutch Shell plc and its subsidiaries in general. Likewise, the words “we”, “us” and “our” are also used to refer to Royal Dutch Shell plc and its subsidiaries in general or to those who work for them. These terms are also used where no useful purpose is served by identifying the particular entity or entities. ‘‘Subsidiaries’’, “Shell subsidiaries” and “Shell companies” as used in this announcement refer to entities over which Royal Dutch Shell plc either directly or indirectly has control. Entities and unincorporated arrangements over which Shell has joint control are generally referred to as “joint ventures” and “joint operations”, respectively.  Entities over which Shell has significant influence but neither control nor joint control are referred to as “associates”. The term “Shell interest” is used for convenience to indicate the direct and/or indirect ownership interest held by Shell in an entity or unincorporated joint arrangement, after exclusion of all third-party interest.

This announcement contains forward-looking statements (within the meaning of the U.S. Private Securities Litigation Reform Act of 1995) concerning the financial condition, results of operations and businesses of Royal Dutch Shell. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. Forward-looking statements are statements of future expectations that are based on management’s current expectations and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in these statements. Forward-looking statements include, among other things, statements concerning the potential exposure of Royal Dutch Shell to market risks and statements expressing management’s expectations, beliefs, estimates, forecasts, projections and assumptions. These forward-looking statements are identified by their use of terms and phrases such as “aim”, “ambition”, ‘‘anticipate’’, ‘‘believe’’, ‘‘could’’, ‘‘estimate’’, ‘‘expect’’, ‘‘goals’’, ‘‘intend’’, ‘‘may’’, ‘‘objectives’’, ‘‘outlook’’, ‘‘plan’’, ‘‘probably’’, ‘‘project’’, ‘‘risks’’, “schedule”, ‘‘seek’’, ‘‘should’’, ‘‘target’’, ‘‘will’’ and similar terms and phrases. There are a number of factors that could affect the future operations of Royal Dutch Shell and could cause those results to differ materially from those expressed in the forward-looking statements included in this announcement, including (without limitation): (a) price fluctuations in crude oil and natural gas; (b) changes in demand for Shell’s products; (c) currency fluctuations; (d) drilling and production results; (e) reserves estimates; (f) loss of market share and industry competition; (g) environmental and physical risks; (h) risks associated with the identification of suitable potential acquisition properties and targets, and successful negotiation and completion of such transactions; (i) the risk of doing business in developing countries and countries subject to international sanctions; (j) legislative, fiscal and regulatory developments including regulatory measures addressing climate change; (k) economic and financial market conditions in various countries and regions; (l) political risks, including the risks of expropriation and renegotiation of the terms of contracts with governmental entities, delays or advancements in the approval of projects and delays in the reimbursement for shared costs; (m) risks associated with the impact of pandemics, such as the COVID-19 (coronavirus) outbreak; and (n) changes in trading conditions. No assurance is provided that future dividend payments will match or exceed previous dividend payments. All forward-looking statements contained in this announcement are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. Readers should not place undue reliance on forward-looking statements. Additional risk factors that may affect future results are contained in Royal Dutch Shell’s Form 20-F for the year ended December 31, 2019 (available at www.shell.com/investor and www.sec.gov). These risk factors also expressly qualify all forward-looking statements contained in this announcement and should be considered by the reader.  Each forward-looking statement speaks only as of the date of this announcement, December 3, 2020. Neither Royal Dutch Shell plc nor any of its subsidiaries undertake any obligation to publicly update or revise any forward-looking statement as a result of new information, future events or other information. In light of these risks, results could differ materially from those stated, implied or inferred from the forward-looking statements contained in this announcement.

We may have used certain terms, such as resources, in this announcement that the United States Securities and Exchange Commission (SEC) strictly prohibits us from including in our filings with the SEC.  Investors are urged to consider closely the disclosure in our Form 20-F, File No 1-32575, available on the SEC website www.sec.gov.

LEI number of Royal Dutch Shell plc: 21380068P1DRHMJ8KU70
Classification: Additional regulated information required to be disclosed under the laws of a Member State



Yamana Gold Advances Projects in Its Generative Exploration Program, Outlines 2021 Plans for Advancing Projects; Reports Positive Advances at Lavra Velha, Monument Bay, Borborema, and Adds Two Early Stage Projects to Program in Chile

d
ownload a PDF of detailed drill hole results for
Lavra Velha 
download a PDF of detailed drill hole results for Monument Bay 
download a PDF of detailed drill hole results for Borborema 
download a PDF of detailed drill hole results for Ivolandia

TORONTO, Dec. 03, 2020 (GLOBE NEWSWIRE) — YAMANA GOLD INC. (TSX:YRI; NYSE:AUY LSE: AUY) (“Yamana” or “the Company”) provided an update on its generative exploration program activities, announcing positive drill results from the Lavra Velha, Monument Bay, and Borborema projects, as well as the addition of two new projects, Cambista and Cambiazo, to the program in Chile.

The generative exploration program is a key component of Yamana’s overall growth strategy, designed to advance the Company’s most prospective properties and lay the foundation for the next generation of Yamana mines. By prudently investing in its exploration project pipeline today, the Company expects to steadily increase its mineral resource base and generate consistent long-term growth in production and cash flow. The Company’s generative work is focused on its large land positions in mining-friendly jurisdictions in the Americas where Yamana already has producing mines and deep technical, geological, and operational expertise. This allows for the rapid advancement of the Company’s highest value projects while at the same time moving the most promising early-stage properties up the exploration pipeline. The main objectives of the generative program are the discovery of a standalone project with inferred mineral resources of at least 1.5 million ounces of gold equivalent within three years that, on a longer-term basis, can support the development of a new cash flow generating mine with production of 150,000 ounces per year for at least eight years.

Projects in the generative exploration program are categorized and defined as follows:

Tier One   Projects with well-defined gold mineral resources and opportunities to grow to a potentially economic threshold in the next three years  
Tier Two   Projects that have achieved significant drill intercepts and whose geology along with other factors support rapid mineral resource growth  
Tier Three   Highly prospective projects with known mineralization defined with rock and soil geochemistry that warrant future drill testing  

The first year of the generative exploration program showed significant progress, notwithstanding limited drilling activity due to COVID-19 related restrictions, strengthening the Company’s conviction that it will meet its objective of discovering a standalone project with inferred mineral resources of at least 1.5 million ounces of gold equivalent within three years. The results also underscore the scope, breadth, optionality, and value of Yamana’s generative portfolio, which now consists of 11 projects including the addition of two new Tier 3 projects, Cambista and Cambiazo, in Chile. Both of these projects, along with several others in the generative portfolio, including Jacobina Norte, are located in close proximity to producing Yamana mines, which will allow the Company to leverage its expertise and experience in these regions to advance the projects and potentially benefit from existing infrastructure should these projects become producing mines. Drill results at Borborema, Ivolandia, and Cambista-Cambiazo show excellent potential to advance to the next tier.

PROJECT SNAPSHOTS

Tier One

  • Lavra Velha (Bahia, Brazil) hosts stacked, flat-lying mineralized zones that are oxidized near surface. Exploration is expanding the known oxide mineral resource base, and the deposit is being evaluated as a potential open pit prospect relying on heap leaching for recovery.
  • Monument Bay (Manitoba, Canada) is a four-kilometre long mineralized Archean shear zone with steeply plunging higher-grade mineralized shoots that is being considered as a potential underground higher-grade prospect.

Tier Two

  • Jacobina Norte (Bahia, Brazil) is a large, highly-prospective property that lies contiguous to and north of the Company’s prolific Jacobina mine, with preliminary results showing excellent potential for the discovery of standalone Jacobina-type mineralization and the addition of a new mine along the greenstone basin.
  • Borborema (Pernambuco, Brazil) hosts newly discovered massive sulphide mineralization that contains high-grade copper as well as gold and zinc. This high-grade mineralization is being delineated, and testing of other copper and gold targets is ongoing.  
  • Ivolandia (Goias, Brazil) is an advancing exploration project where drilling has defined wide low-grade mineralized zones. Exploration is focussed on oxidized, near-to-surface zones of gold mineralization that are potentially well-suited to open pit heap leach extraction.
  • Domain (Manitoba, Canada) hosts iron formation gold mineralization that has been identified by limited historic drilling. It is a large property with untested iron formation and shear zone type targets that Yamana expects to begin drill testing in 2021 pending the conclusion of community consultation and permitting.

Tier Three

  • North Madsen (Ontario, Canada) is located in the Red Lake district in northwest Ontario, where intrusive hosted vein and stockwork gold mineralization generates both wide, low-grade mineralized zones and higher-grade vein and shear-hosted mineralization. The mineralized zones are currently being evaluated for higher-grade mineralization that could be amenable to underground mining.
  • Colider (Mato Gross, Brazil) is an early stage project in the newly developing Juruena District that has been explored for porphyry copper and precious metals deposits by several junior and senior companies. The property has defined gold-in-rock and soil anomalies associated with well preserved epithermal style mineralization in a Proterozoic arc setting. Targets are ready for first pass drill testing.
  • Cambista and Cambiazo (Antofagasta, Chile) are two early-stage properties with an extensive portfolio of mineral concessions located within 100 kilometres of the Company’s El Peñón mine. Recent exploration has identified significant areas of alteration with associated anomalous gold results in soil and rock samples and limited but encouraging gold mineralization in drill intercepts. Drill testing is ongoing.
  • Mara Rosa (Goias, Brazil) is a large land package marked by the same alteration footprint as the Chapada mine, with significant copper, copper-gold, and gold-only targets, several of which are drill ready. Further geochemical exploration is planned in 2021.

Figure 1: Project Location Map
.

https://www.globenewswire.com/NewsRoom/AttachmentNg/0896239b-b0a1-483d-ab65-43940d8511dc

TIER ONE PROJECTS

Lavra Velha

Lavra Velha is an advanced exploration project located on a 55,000-hectare land package in Brazil’s Bahia state, a mining-friendly jurisdiction that is also home to Yamana’s Jacobina mine. Lavra Velha is located about 300 kilometres from Jacobina and could share potential synergies with the mine operation. The generative exploration program has already identified inferred mineral resources at Lavra Velha of 3.93 million tonnes at 4.29 grams per tonne (“g/t”) of gold for 543,000 ounces of gold, which represents one-third of the 1.5 million ounces of inferred mineral resources being targeted by the Company under the generative exploration program.

Exploration continues to generate and test new prospective areas within and around the Lavra Velha deposit with a focus on shallow oxide mineralization. Step out exploration has led to the further discovery and partial delineation of the Lavra Velha SW and Sul deposits. These areas consist of a series of structural zones defined over more than 900 metres of strike length. Shallow drilling in 2020 has yielded significant results from oxide mineralized zones, as represented by the following estimated true width intercepts: 5.80 metres at 2.35 g/t of gold (from hole FSW-018, starting at 56.20 metres down hole); 4.89 metres at 2.18 g/t of gold (hole FLV00161, starting at starting at 63.00 metres down hole); and 9.44 metres at 0.64 g/t of gold, including 0.84 metres at 2.84 g/t of gold (hole FSW-020, starting at 101.00 metres down hole).

Historic drill intercepts of note from the Lavra Velha SW and Sul deposits include the following estimated true width intercepts: 4.90 metres at 3.95 g/t of gold (hole FLV-136, starting at 26.40 metres down hole); 11.21 metres at 3.63 g/t of gold, including 2.05 metres at 10.30 g/t of gold (hole FLV-146, starting at 98.13 metres down hole) and 12.67 metres at 1.94 g/t of gold (FLV-068, starting at 1.20 metres down hole). See Figure 2 for a project map and Table 1 for additional drill results. These results as well as other previously released results (see the Yamana press release issued February 20, 2020, available on the Company’s website at www.yamana.com) will be used to update the mineral resources, and are expected to add to the already identified oxide mineral resource.

To the southeast of the Lavra Velha deposit, a similar geological setting has been explored in the Flanco Leste area. Recent geochemical results from surface rock sampling has defined a large, continuous anomalous zone along a 3.5 kilometre strike associated with alteration similar to that present at higher levels of the Lavra Velha deposit. Exploratory drilling has been initiated to test this area and will continue in early 2021.

Metallurgical studies were initiated to determine the suitability of Lavra Velha mineralization for heap leach extraction. Bottle roll tests were executed at SGS laboratory (Belo Horizonte, Minas Gerais) with a total of 39 oxide samples tested. One kilogram splits of material with 100% passing six millimetres were analyzed by sampling at five fixed intervals of 2, 4, 8, 24, and 72 hours. The initial results show that the oxide mineralization may be suitable for gold recovery by heap leaching, with an average of 94.6% gold extraction in under 72 hours. Similar tests on sulphide bearing material showed recoveries that averaged 87% for mixed sulphide and oxide domains and 75% for sulphide only domains. Additional metallurgical studies are underway that will include larger-scale column tests and cyanide consumption analysis, with results expected by mid-year 2021.

Lavra Velha represents one of the best prospects in the generative exploration program, and Yamana believes there is excellent potential for the project to meet the Company’s three-year, 1.5 million ounce inferred mineral resource target.

Figure 2
:
Lavra Velha project
map showing
main
mineralized
sector
s, rock sample results and 2020 and historic drilling highlights
for Lavra Velha Sul and Lavra Velha SW,
reported as Au
(g/t)
over estimated true widths
.

https://www.globenewswire.com/NewsRoom/AttachmentNg/c003f51f-fb0f-450c-838c-5e7e369ccdcc

T
able
1
: Lavra Velha
2020 and historic
drilling highlights.

Hole Including Sector From

(m)
To

(m)
Interval

(m)
Estimated
True Width
(m)
Au

(g/t)
Year
FSW-016   Lavra Velha Sul 76.00 89.91 13.91 13.30 0.45 2020
Incl. Lavra Velha Sul 76.00 76.65 0.65 0.65 1.10 2020
Incl. Lavra Velha Sul 89.34 89.91 0.57 0.57 4.45 2020
FSW-018   Lavra Velha Sul 56.20 62.00 5.80 5.80 2.35 2020
Incl. Lavra Velha Sul 56.20 56.93 0.73 0.73 6.78 2020
Incl. Lavra Velha Sul 61.03 62.00 0.97 0.97 6.48 2020
And Lavra Velha Sul 117.00 126.19 9.19 9.19 0.60 2020
FSW-020   Lavra Velha Sul 101.00 110.44 9.44 9.44 0.64 2020
Incl. Lavra Velha Sul 101.00 101.84 0.84 0.84 2.84 2020
FLV00161   Lavra Velha Sul 63.00 68.00 5.00 4.89 2.18 2020
Incl. Lavra Velha Sul 65.19 66.20 1.01 0.98 9.65 2020
FLV-068   Lavra Velha SW 1.20 13.87 12.67 12.67 1.94 Historic
Incl. Lavra Velha SW 10.15 12.00 1.85 1.85 8.30 Historic
FLV-136   Lavra Velha Sul 26.40 35.51 9.11 4.90 3.95 Historic
Incl. Lavra Velha Sul 27.61 33.15 5.54 2.98 5.56 Historic
FLV-146   Lavra Velha SW 98.13 110.58 12.45 11.21 3.63 Historic
Incl. Lavra Velha SW 93.13 100.41 2.28 2.05 10.30 Historic
Incl. Lavra Velha SW 105.00 109.00 4.00 3.60 4.65 Historic

Monument Bay

Yamana continues to explore its 31,000-hectare Monument Bay project, located in northeastern Manitoba. The Twin Lakes deposit was originally being considered as an open pit operation but is now being re-evaluated as an underground project based on encouraging results from an internal study consisting of a stope optimization exercise within a revised deposit interpretation. The internal study indicates the presence of steeply plunging higher-grade shoots within the open pit resource that are potentially mineable in an underground scenario. Where possible, mineralized shoots were extended up to a maximum depth of 700 metres to produce target shapes to guide the next phase of deposit drilling.

While an underground project would reduce the overall mineral resource, grades would be expected to increase and, consequently, potentially improve economics. In addition, the mineralized shoots are open at depth, which means the initial mineral resource could increase. Further, an underground scenario would reduce the project footprint, mitigating the surface impact and lowering its overall environmental footprint.

Encouraging drill results from the winter 2020 program include the following estimated true width intercepts: 14.86 metres at 3.32 g/t of gold, including 7.20 metres at 5.58 g/t of gold (TL-20-703); 7.46 metres at 6.68 g/t of gold (TL-20-712); 4.06 metres at 8.64 g/t of gold, including 3.07 metres at 10.73 g/t of gold (TL-20-715); and 4.64 metres at 5.29 g/t of gold (TL-20-702). The results confirm the presence of higher grade and wide structures and zone extensions at shallow elevations not currently within the model, underscoring the potential within the deposit footprint both near surface and at depth. See Figure 3 for a long section of the Monument Bay Twin Lakes deposit and Table 2 for additional drill results.

Drilling activity in 2020 was impacted by restrictions related to COVID-19, but the exploration program will now ramp up taking advantage of winter ice conditions, with rigorous COVID-19 precautionary measures in place and rapid testing available to protect local communities and project personnel. More drilling results are expected by the middle of 2021.

In order to guide a 16,000-metre winter surface drilling program along the deposit trend, a series of three drill holes were completed during the recent fall program. Full results are pending but core logging confirms the presence of characteristic deposit mineralization and alteration features at depth, with preliminary associated anomalous gold values. Results will be reported along with the planned drill program in 2021.

In early 2020, a reverse circulation drill till sampling program continued across the property, testing areas not previously targeted. Till and top of bedrock results further support interest in an emerging target area southeast of the Twin Lakes deposit. Exploration on this target area is expected to resume in 2021.

Figure 3
:
Monument Bay Twin Lakes Deposit
l
ong
s
ection
with modeled geologically defined gold domains
as well as
target gold domains
projected
to 700 m
etres
depth. 2019 and 2020 drilling results
and
select historic intercepts
,
reported as Au
(g/t)
over estimated true widths,
shown to illustrate higher

grade values within gold domains.

https://www.globenewswire.com/NewsRoom/AttachmentNg/0f359441-38bc-4128-aa5d-9bba5c845212

Hole Including From

(m)
To

(m)
Interval

(m)
Estimated
True Width
(m)
Au

(g/t)
Year
TL-19-696   160.37 169.65 9.28 8.98 3.71 2019
Incl. 162.37 166.25 3.88 3.76 7.54 2019
Incl. 163.70 166.25 2.55 2.47 9.68 2019
TL-19-697B   161.50 167.40 5.90 5.22 4.32 2019
And 181.03 183.65 2.62 0.81 27.12 2019
Incl. 181.03 182.65 1.62 0.50 43.09 2019
TL-20-702   26.45 31.30 4.85 4.64 5.29 2020
Incl. 26.45 27.40 0.95 0.91 12.43 2020
TL-20-703   132.00 149.07 17.07 14.86 3.32 2020
Incl. 140.50 148.77 8.27 7.20 5.58 2020
TL-20-712   26.00 34.15 8.15 7.46 6.68 2020
TL-20-714   116.70 124.90 8.20 7.83 2.44 2020
Incl. 116.70 119.70 3.00 2.87 5.39 2020
Incl. 118.90 119.70 0.80 0.76 18.30 2020
And 131.90 137.60 5.70 5.58 3.43 2020
TL-20-715   96.00 100.10 4.10 4.06 8.64 2020
Incl. 97.00 100.10 3.10 3.07 10.73 2020
And 165.00 167.80 2.80 2.78 5.87 2020
Incl. 165.75 167.80 2.05 2.03 7.50 2020

TIER
2
PROJECTS

Jacobina Norte

The Jacobina Norte project, located in Brazil’s Bahia State contiguous to and north of the Jacobina mine property, comprises a total of 78,000 hectares of exploration concessions distributed along a 150-kilometre-long strike length extent of the Serra do Corrego formation, which hosts the paleoplacer gold mineralization of the Jacobina mine. Surface work, which started in 2019 and continued in 2020, has defined mineralized conglomerate reefs along a trend that is more than 15-kilometres long. An exploratory drilling program was recently initiated covering several well defined mineralized sectors, while district exploration continues to explore for new mineralized sectors north of areas currently being drilled.

Surface work at Jacobina Norte has defined three sectors, Angicos, Barracão, and Barracão Velho, where gold-in-rock samples related to multiple, staked, continuous conglomerate reefs, defined a 15-kilometre target area within a geological setting that is closely comparable to the paleoplacer gold mineralization found at the Jacobina mine. In all three sectors, at least four distinct conglomerate layers have been defined, ranging from four to five metres in thickness and presenting numerous gold values above 1.0 g/t of gold, with assays ranging up to 5.8 g/t of gold in some areas. Drilling is continuing and will test widely spaced targets to rapidly define the highest priority areas for advancement.

District exploration beyond the northern limits of the Angicos-Barrãcao area has identified several other areas of conglomerate hosting anomalous gold values in areas up to 40 kilometres north of Barracão Velho. See Figure 4 for a project map and main exploration targets as well as planned drilling.

The results generated from the first-year program at Jacobina Norte show impressive exploration potential, with strong evidence of favourable geological features that make the Jacobina mine a multimillion ounce gold deposit.

Figure 4
:
Jacobina Norte project and main explored sectors
.

https://www.globenewswire.com/NewsRoom/AttachmentNg/6057e6a8-5ef4-4ba9-b425-5f263cd55a95

Borborema

The Borborema project is a 25,000-hectare land package located in Brazil’s Pernambuco state in a Proterozoic magmatic arc environment that is similar to the belt hosting the Chapada mine, a large copper-gold mine developed by Yamana and put into production in 2007. Recent generative exploration work at Borborema has led to the discovery of important, high-grade copper-gold-zinc massive sulphide mineralization that has produced notable drill intercepts in initial drilling and defined several other high potential targets on the property.

The drilling program at São Francisco has successfully delineated a continuous 900-metre long copper-gold-zinc massive sulfide mineralized body that runs in an east-west direction, gently plunging to the east and enveloped by a large halo of lower-grade disseminated sulphide mineralization. Both the halo and massive sulphide mineralization remain open for expansion. Drilling results demonstrate that the São Francisco discovery is a significant polymetallic system with associated gold, as defined by the following recent core length intercepts (estimated to approximately equal true widths): 7.53 metres at 3.80% of copper, 0.36 g/t of gold, and 0.26% of zinc, including 3.42 metres at 7.40% of copper, 0.75 g/t of gold, and 0.50% of zinc (starting at 76.80 metres downhole, SF-12); 4.37 metres at 2.15% of copper, 0.13 g/t of gold, and 0.34% of zinc, including 1.30 metres at 5.54% of copper, 0.29 g/t of gold, and 0.70% of zinc (starting at 45.26 metres downhole, SF-09); and 5.65 metres at 1.83% of copper, 0.18 g/t of gold, and 0.17% of zinc, including 1.65 metres at 5.50% of copper, 0.50 g/t of gold, and 0.53% of zinc (starting at 116.35 metres downhole, SF-16). See Figure 5 and Table 3 for additional drill results.

The district exploration has also identified seven new areas within the Borborema exploration concessions with large gold, gold-copper or copper soil and rock anomalies from surface sampling, expanding the São Francisco footprint and providing new areas for drill testing.

The results demonstrate that São Francisco represents a significant, shallow copper-gold-zinc system defined by a continuous massive sulphide rich core enveloped by a wide zone of disseminated mineralization, which is completely open for expansion in all directions. The drilling program will continue to focus on expanding the known mineralized system.

São Francisco mineralization represents only a minor portion of a large anomalous district, making Borborema a very attractive project in the Company’s exploration portfolio.

Figure 5
:
Borborema
property,
S
ã
o Francisco
target 2020 drilling highlights
and main district sector location
. Drilling results reported as Cu (%), Au (g/t) and Zn (%) over core lengths.

https://www.globenewswire.com/NewsRoom/AttachmentNg/b2b19b7f-1d36-49ab-95b2-02c3ddbaddd9

T
able
3
: Borborema
2020
drilling
highlights
for
drill holes
demonstrating grades greater than
5.0
% Cu
over core
lengths
greater than 0.5 metres
.

Hole Including Sector From

(m)
To

(m)
Interval

(m)
Cu

(%)
Au

(g/t)
Zn

(%)
Year
SF-09   São Francisco 45.26 49.63 4.37 2.15 0.13 0.34 2020
Inc. São Francisco 47.30 48.60 1.30 5.54 0.29 0.70 2020
Inc. São Francisco 47.30 47.92 0.62 9.61 0.46 1.00 2020
SF-10   São Francisco 59.37 63.51 4.14 1.09 0.07 0.16 2020
Inc. São Francisco 59.97 60.62 0.65 6.00 0.35 0.66 2020
SF-11   São Francisco 69.91 73.09 3.18 1.21 0.20 0.23 2020
Inc. São Francisco 71.88 73.09 1.21 3.08 0.53 0.51 2020
Inc. São Francisco 71.88 72.48 0.60 5.86 1.06 1.00 2020
SF-12   São Francisco 76.80 84.33 7.53 3.80 0.36 0.26 2020
Inc. São Francisco 80.20 83.62 3.42 7.40 0.75 0.50 2020
SF-16   São Francisco 116.35 122.00 5.65 1.83 0.18 0.17 2020
Inc. São Francisco 116.35 118.00 1.65 5.50 0.50 0.53 2020
Inc. São Francisco 116.35 117.35 1.00 7.24 0.66 0.72 2020

Ivolandia

The Ivolandia project is comprised of a 67,500-hectare land package that is located in Brazil’s Goias state south of the Chapada mine. Geochemical stream and soil sampling on the exploration concessions has identified numerous large gold anomalies, and an initial drilling program has defined shallow, gold oxide mineralization.

At the Ivolandia Main target, 36 exploratory drill holes have defined a low-grade oxide mineral envelope over a 1.2 kilometre north-south extent, supported by the following recently drilled core length intercepts: 31.57 metres at 0.44 g/t of gold (from surface), including 5.57 metres at 1.55 g/t of gold (IVO-018); 24.00 metres at 0.30 g/t of gold (from surface), and 25.30 metres at 0.50 g/t of gold (starting at 52.00 metres down hole, IVO-023). See Figure 6 for a property map and drilling highlights.

New sectors have also been defined through exploratory drilling, including Ivolandia West, that warrant further exploration, as indicated by the following low-grade core length intercepts: 15.00 metres at 0.33 g/t of gold (starting at 53.00 metres downhole), and 1.00 metres at 3.03 g/t of gold (starting at 156.00 metres down hole, IVO-29). True widths are not interpreted at this time.

Within the greater Ivolandia concessions, exploration results have defined a number of gold targets for further drill testing. In one of the sectors, Guarda Mor, historical holes drilled by Yamana intercepted significant higher-grade shallow oxide mineralization as indicated by core length intercepts in holes GMOR-04 (21.71 metres a 4.75 g/t of gold, starting at 20.34 metres downhole) and GMOR-14 (13.00 metres at 0.63 g/t Au, starting at 44.00 metres downhole), confirming significant district scale potential for further discovery.

Figure
6
:
Ivolandia project
,
Ivolandia
Main target 2020
drilling
highlights
,
property wide gold grain stream sediment counts and
select historic
exploratory drilling.
Drilling results reported as Au
(g/t)
over core lengths.

https://www.globenewswire.com/NewsRoom/AttachmentNg/d0023613-b35c-4be9-8e65-ac744c88139a

Domain

The Domain project, located near Oxford Lake in northeastern Manitoba, is a large 20,000-hectare property package consisting of two unexplored mineral exploration licences 100%-controlled by Yamana, and three smaller claims held under a joint venture agreement with Capella Minerals Ltd. The property is considered to be highly prospective for iron formation-hosted gold deposits and has returned a number of drill intercepts with significant gold grades from a limited area of drilling within the joint venture claims. The larger land package has magnetic anomalies and limited arsenic-in-till anomalies that indicate potential targets for further iron formation-hosted gold as well as shear zone type gold targets.

In July 2020, Yamana entered into an Exploration Agreement with Bunibonibee Cree Nation to develop a cooperative and mutually beneficial relationship relating to mineral exploration within the Traditional Territory of Bunibonibee Cree Nation. Yamana is in the planning stages of a work program for the property, and pending conclusion of community consultation and permitting, exploration work is anticipated to begin in early 2021.

TIER THREE PROJECTS

Yamana controls a number of prospective land packages with evidence of mineralization on surface and limited or no drilling completed to date. These Tier Three projects represent important opportunities that the Company believes offer excellent exploration upside, providing an opportunity for organic growth of new advanced exploration projects over the next decade. Notable Tier Three projects include Cambista and Cambiazo in Chile, Colider in Brazil, and North Madsen in Canada.

Cambista and Cambiazo

Yamana controls an extensive portfolio of exploration properties located within 100 kilometres of the El Peñón mine. Concessions totalling approximately 71,000 hectares are located in this Paleocene gold belt that hosts the El Peñón mine, which has produced over five million ounces of gold to date. The Company’s knowledge and exploration expertise of this environment are now being applied to exploration in the outlying concessions. Exploration has been successful in identifying several high potential sectors utilizing spectrometry-based alteration mapping, soil geochemistry, and the reinterpretation of geophysical data.

Ongoing first pass exploratory drilling has intercepted significant areas of alteration and limited but encouraging evidence of gold mineralization. Initial drilling in one sector, Faraón, located in the northern section of the area being targeted, yielded 34.00 metres at 0.51 g/t of gold, including 2.00 metres at 3.13 g/t of gold (hole CLGNRC05, starting at 146.00 metres downhole). True widths are not interpreted at this time. See Figure 7 for a property location map.

Several others concessions within this well-endowed mineral belt that the Company believes demonstrate high potential for further discoveries are being advanced to drill testing stage.

Figure 7: Cambista
and
Cambiazo
p
ropert
y
locations, El Pe
ñó
n District,
northern
Chile.

https://www.globenewswire.com/NewsRoom/AttachmentNg/bf259f8d-c3c4-478f-aa8d-d768388d439c

C
olider

Colider is an early stage project located in Mato Grosso, Brazil, in the newly developing Juruena District, which has been explored for porphyry copper and precious metals deposits by several junior and senior companies. The 9,700-hectare property is located on Proterozoic volcanic rocks of the Colider sequence. Initial exploration has identified areas of anomalous gold in soils and rocks, with values in individual soil samples reaching up 0.1 g/t of gold intermittently over up to 5.0 kilometres. Gold-in-rock anomalies are associated with well preserved epithermal vein and stockwork mineralization. Exploratory drilling is planned to test these targets in 2021.

Figure 8
:
Colider project, Brazil.
G
eology and rock and soil gold geochemistry.

https://www.globenewswire.com/NewsRoom/AttachmentNg/f34fc693-32b7-4578-83d4-e32280278029

North Madsen

At North Madsen, a 416-hectare property located in the core of the Red Lake camp in Ontario, gold mineralization is present as intrusive-hosted vein and stockwork, with both significant wide, low-grade intercepts and more restricted higher-grade mineralized intervals. A 2020 review of historic drilling produced an internal project evaluation that has generated renewed interest to further evaluate the project. Previous exploration has outlined gold zones in three separate areas, each of which is contiguous with gold zones on the adjacent Hasaga property owned by Premier Gold Mines Ltd. Further work will focus on developing an improved geologic model to evaluate near surface targets as well as the potential to develop higher-grade targets that are potentially amenable to underground mining.  

QP Statement

Scientific and technical information contained in this press release has been reviewed and approved by Henry Marsden (P. Geo. and Senior Vice President, Exploration). Mr. Marsden is an employee of Yamana Gold Inc. and a “Qualified Person” as defined by Canadian Securities Administrators’ National Instrument 43-101 – Standards of Disclosure for Mineral Projects.

Quality Assurance and Quality Control

Yamana incorporates a Quality Assurance and Quality Control (“QA/QC”) program for all of its mines and exploration projects which conforms to industry best practices.

Samples are transported in security sealed bags for preparation at  certified laboratories (ALS, SGS, BVS). Gold is analyzed by gold fire assay with 30 grams or 50 grams aliquot and AAS finish. Samples over 5 g/t are re-analyzed by gravimetric finish methods. Silver is determined using a four acid digestion and AAS finish (ore level) and samples over 30g/t are re-analyzed by gravimetric finish methods. Copper reported in this release is analyzed by AAS using a four acid digestion. Five percent of all pulps are further checked by secondary certified laboratories (ALS, SGS, Bureau Veritas) using the same analytical methods.

All exploration diamond drill cores are split in half by mechanical spitting or core sawing and sampled at appropriate intervals for assay The remaining core, coarse reject and pulps are stored on-site in a secure location.

Quality assurance standards, duplicates, sterile and blanks are routinely inserted into the sample stream as a control for assay accuracy, bias, precision and contamination. The results of these checks are tracked and failures are re-analyzed. This information also includes pulp checks carried out in the secondary lab.

About Yamana

Yamana Gold Inc. is a Canadian-based precious metals producer with significant gold and silver production, development stage properties, exploration properties, and land positions throughout the Americas, including Canada, Brazil, Chile and Argentina. Yamana plans to continue to build on this base through expansion and optimization initiatives at existing operating mines, development of new mines, the advancement of its exploration properties and, at times, by targeting other consolidation opportunities with a primary focus in the Americas.

FOR FURTHER INFORMATION, PLEASE CONTACT:

Investor Relations
416-815-0220
1-888-809-0925
Email: [email protected]

Tavistock (UK Public Relations)

Charles Vivian / Emily Moss
Telephone: +44 7977 297 903 / +44 778 855 4035
Email: [email protected]

Peel Hunt LLP (Joint UK Corporate Broker)

Ross Allister / David McKeown / Alexander Allen
Telephone: +44 (0) 20 7418 8900

Berenberg (Joint UK Corporate Broker)

Matthew Armitt / Jennifer Wyllie / Detlir Elezi
Telephone: +44 (0) 20 3207 7800

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: This news release contains or incorporates by reference “forward-looking statements” and “forward-looking information” under applicable Canadian securities legislation and within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking information includes, but is not limited to information with respect to the Company’s proposed generative exploration program and prospective and highly prospective targets and projects, the Company’s short-term and longer-term goals and objectives of the program; the Company’s expectation that it will continue to generate cash flow, some of which will support the generative exploration program. Forward-looking statements are characterized by words such as “plan”, “expect”, “budget”, “target”, “project”, “intend”, “believe”, “anticipate”, “estimate” and other similar words, or statements that certain events or conditions “may” or “will” occur. Forward-looking statements are based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made, and are inherently subject to a variety of risks and uncertainties and other known and unknown factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. These factors include unforeseen impacts on cash flow; unforeseen exploration and test results, and other risk factors discussed in the Company’s Annual Information Form filed with the securities regulatory authorities in all provinces of Canada and available at www.sedar.com, and the Company’s Annual Report on Form 40-F filed with the United States Securities and Exchange Commission.  Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward-looking statements if circumstances or management’s estimates, assumptions or opinions should change, except as required by applicable law. The reader is cautioned not to place undue reliance on forward-looking statements. The forward-looking information contained herein is presented for the purpose of assisting investors in understanding the Company’s proposed generative exploration program and the short-term and longer-term goals and objectives thereof, as well as the Company’s expected sources of funding for the program and may not be appropriate for other purposes.

 



Skanska sells office building in Warsaw, Poland, for EUR 70 M, about SEK 720 M

PR Newswire

ÖSTERSUND, Sweden, Dec. 3, 2020 /PRNewswire/ — Skanska sells the second building from the Spark office complex located in Warsaw, Poland, to Stena Fastigheter AB for EUR 70 M, about SEK 720 M. The transaction will be recorded by Skanska Commercial Development Europe in the fourth quarter of 2020. The transfer of the property is scheduled for the first quarter of 2021.

This is the second phase of the Spark office complex, a part of a three-building office complex. It is located in the heart of Wola, one of the fastest growing business and office districts in Warsaw. The building consists of approximately 19,000 square meters and about 85 per cent is leased to international as well as domestic tenants including UPC Polska, PCF Group, PKO Faktoring and INC Research (Syneos) among others.

The sold property was completed in the first quarter of 2019. It has already achieve d LEED Platinium as well as Building without barriers certifications. In addition it is also expected to receive WELL Core & Shell (Gold) certification and be accepted in the WELL Health-Safety Rating which awards high-quality office spaces with top safety standards that reduce the risk of disease transmission and facilitate creating healthy and safe workplaces. 

Skanska is one of the leading development and construction companies in Europe. Outside the Nordics, the company has operations in building construction and civil engineering in Poland, Czech Republic & Slovakia and the UK. Skanska develops commercial properties in selected home markets in Poland, Czech Republic, Romania and Hungary, while residential development is active in Poland, Czech Republic and in the UK with the BoKlok concept. In 2019, Skanska had sales of SEK 33 billion and about 11,700 employees in its European operations outside the Nordics.

CONTACT:

For further information please contact:

Aleksandra Markiewicz, Communications Manager, Skanska CDE, tel +48 797 229 147

Olof Rundgren, Media Relations Manager, Skanska AB, tel +46 (0)10-448 67 94

Direct line for media, tel +46 (0)10 448 88 99

This and previous releases can also be found at

www.skanska.com
.

 

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/skanska/r/skanska-sells-office-building-in-warsaw–poland–for-eur-70-m–about-sek-720-m,c3248226

The following files are available for download:

Cision View original content:http://www.prnewswire.com/news-releases/skanska-sells-office-building-in-warsaw-poland-for-eur-70-m-about-sek-720-m-301185403.html

SOURCE Skanska

/C O R R E C T I O N from Source — EXFO Inc./

PR Newswire

In the news release “EXFO solves video streaming problems for service providers”, issued 03-Dec-2020 by EXFO Inc. over CNW Telbec, we are advised by the company that the link “Nova Active over-the-top (OTT) video monitoring” was erroneous. The complete, corrected release follows:

EXFO solves video streaming problems for service providers

Industry-first solution brings new revenue opportunities, reduces churn, and differentiates

QUEBEC CITY, Dec. 3, 2020 /PRNewswire/ – EXFO Inc. (NASDAQ: EXFO) (TSX: EXF), the communications industry’s test, monitoring and analytics experts, today launched Nova Active over-the-top (OTT) video monitoring, an industry-first solution allowing service providers to automatically detect and diagnose the root cause of video streaming problems as soon as they begin, and identify their origin—whether inside or outside of their networks. This is critical as video exceeds 65% of today’s network traffic, and will rise to over 90% in 5G networks by 2024.

OTT video streaming issues are the number one source of network-related customer churn


1


, a multimillion dollar problem for operators.2 In addition, consumers blame their video quality of experience (QoE) issues primarily on service providers,3 even though approximately half of all video quality issues originate outside of their networks and their control.4

As a result, service providers have high volumes of churn and are unable to effectively monetize OTT video services and leverage QoE as an essential differentiator. In turn, revenue losses and higher customer acquisition costs increase as the provider’s reputation suffers—even if the issues stem from a customer device, a poor home WiFi network or a content provider’s data center issue.

EXFO’s Nova Active OTT video monitoring solution now gives mobile network operators, internet service providers and content delivery providers the means to detect, segment, classify and diagnose the root cause of video streaming problems as soon as they begin. For the first time, service providers will be able to pinpoint whether problems like freezing, buffering or lagging come from their network, the video platform, the user’s device, or a video provider like YouTube or Netflix.

“As we all increasingly rely on video streaming for working, learning and socializing, the quality of over-the-top video services has never been more important. But until now, service providers did not have access to technology allowing them to quickly identify and solve video streaming problems, whether on mobile devices, at work or at home,” said Abdelkrim Benamar, EXFO’s Vice President of Service Assurance, Systems and Services. “EXFO’s unique solution will give service providers the ability to quickly pinpoint the source of these problems, resolve video quality issues for users and capture the growing opportunity that video represents.”

“Legacy video monitoring solutions are generally expensive, compute-intensive and tailored to content delivery applications. The industry needs real-time video monitoring that helps service providers overcome network issues, where the majority of issues originate,” said Gorkem Yigit, Lead analyst for the Cloud Infrastructure Strategies and Media Platforms research programs, Analysys Mason. “EXFO’s approach is designed to address this with an innovative approach that provides visibility into video quality, network performance and how they relate, so providers can optimize user experience with what’s within their control.”

Nova Active OTT video monitoring is an integral part of the Nova Active monitoring solution and the Nova Adaptive Service Assurance platform. Using a patent-pending approach that measures video streaming experience without compromising user privacy, operators can precisely identify, classify and localize issues as they occur. The new solution avoids big data analytics and decryption delays, allowing operations teams to prioritize and take immediate action.

Key benefits of the solution include:

  • Delivering end-to-end visibility of OTT services.
  • Supporting operators’ goals for 5G evolution.
  • Providing operators with the tools needed to manage the explosion in OTT video services.
  • Provides an extensible platform for keeping pace with ever evolving OTT services.
  • A 100% secure and private solution.
  • Monitoring video quality in near real time (per second VQS generation).

More information about the solution is available on EXFO.com.

About EXFO

EXFO (NASDAQ: EXFO) (TSX: EXF) develops smarter test, monitoring and analytics solutions for fixed and mobile network operators, webscale companies and equipment manufacturers in the global communications industry. Our customers count on us to deliver superior network performance, service reliability and subscriber insights. They count on our unique blend of equipment, software and services to accelerate digital transformations related to fiber, 4G/LTE and 5G deployments. They count on our expertise with automation, real-time troubleshooting and big data analytics, which are critical to their business performance. We’ve spent over 35 years earning this trust, and today 1,900 EXFO employees in over 25 countries work side by side with our customers in the lab, field, data center and beyond.

Blog:
https://bit.ly/39v5oH0 
Webinar: https://bit.ly/36p7ypE 

____________________


1

Ipsos 2019 survey, Sapio Research consumer survey, Nov-2020


2

Sapio Research consumer survey, Nov-2020, EXFO market analysis


3

Idem.


4

Source RCR / EXFO global video monitoring research, 2020-09.

 

Cision View original content:http://www.prnewswire.com/news-releases/exfo-solves-video-streaming-problems-for-service-providers-301185398.html

SOURCE EXFO Inc.

Clean Power Capital Corp. Announces Plans to List on NASDAQ

VANCOUVER, British Columbia, Dec. 03, 2020 (GLOBE NEWSWIRE) — Clean Power Capital Corp. (CSE: MOVE)(FWB: 2K6)(OTC: MOTNF) (“Clean Poweror the “Company” or MOVE“). The Company is pleased to announce that the Board of the Company has formed a strategic committee (the “Strategic Committee”) to review and develop a strategy to enhance its investor profile by launching a new capital markets strategy focused on the United States. As part of the strategy, the Strategic Committee will consider an application to list its common shares on the NASDAQ Capital Market (“NASDAQ”).

The acceptance of the application to list the Company’s common shares on NASDAQ will be subject to a number of regulatory and listing requirements, including without limitation: retaining the required number of market makers for the Company’s common shares; engaging a sponsor for the Company’s common shares; the filing of the applicable registration statement with the U.S. Securities and Exchange Commission to become a reporting company under the U.S. Securities Act; and the review of the Company and acceptance for listing by NASDAQ. The Company will also seek a financial advisor to assess the viability of a potential up-listing to NASDAQ. There can be no assurance that NASDAQ acceptance will be granted should the Company submit its listing application.

Management of MOVE believes up-listing to NASDAQ will:

  • provide additional opportunities to attract institutional and retail investors, allowing the Company to broaden its investor base in the United States and internationally;
  • increase the visibility of the Company, its growth strategy, accomplishments and results to date;
  • increase liquidity of the Company’s common shares; and
  • raise the Company’s overall profile and ultimately enhance shareholder value.

Joel Dumaresq, CEO of the MOVE stated, “We continue to see strong interest from investors both in the U.S. and internationally. An up-listing to the NASDAQ has been on our radar as one of the many strategies to execute as part of our capital markets strategy and in accordance with the Company’s Investment Policy with the paramount goal of the Company to generate maximum returns from its investments. Given that a NASDAQ listing is a natural next step for the Company.”

The listing of the Company’s common shares on the NASDAQ remains subject to the approval of the NASDAQ and the satisfaction of all applicable listing and regulatory requirements. The Company will continue to maintain the listing of its common shares on the Canadian Securities Exchange under the symbol “MOVE”. The Company will provide updates on its progress as it moves toward this goal.

There is currently no timeline for completion of the review of our capital markets strategy, and there is no assurance that these efforts will be successful or that the review process will result in the listing of the Company’s common shares on NASDAQ.

About PowerTap

The Company completed an investment in PowerTap on October 27, 2020 (see the Company’s news release on October 28, 2020). PowerTap is leading the charge to build out cost-effective hydrogen fueling infrastructure through its environmentally friendly intellectual property, product design for the modularized and lowest tier production cost of hydrogen, and launch plan.   PowerTap technology-based hydrogen fueling stations are located in private enterprises and public stations (near LAX airport) in California, Texas, Massachusetts, and Maryland. Additional information about PowerTap may be found at its website at http://www.powertapfuels.com

ABOUT
CLEAN POWER
CAPITAL CORP.

Clean Power is an investment company, that specializes in investing into private and public companies opportunistically that may be engaged in a variety of industries, with a current focus in the health and renewable energy industries. In particular, the investment mandate is focused on high return investment opportunities, the ability to achieve a reasonable rate of capital appreciation and to seek liquidity in our investments. A copy of Clean Power’s amended and restated investment policy may be found under the Company’s profile at www.sedar.com.

ON BEHALF OF THE
CLEAN POWER
CAPITAL CORP.
BOARD OF DIRECTORS

“Joel Dumaresq”

Joel Dumaresq, CEO
+1 (604) 687-2038
i[email protected]

Learn more about Clean Power by visiting our website at: https://cleanpower.capital/

Notice Regarding Forward Looking Information:

This press release contains “forward-looking information” and “forward-looking statements” (together, “forward-looking statements”) within the meaning of applicable Canadian and United States securities laws. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. Forward-looking information in this press release includes statements relating to the Company’s consideration of applying to list its common shares on NASDAQ, the Company’s ability to increase its liquidity and capital markets exposure if the NASDAQ listing application is submitted and is successful, the Company receiving all required approvals in respect of a potential NASDAQ listing application and the commencement of trading of the Company’s Common Shares on the NASDAQ should a listing application be submitted and accepted, the planned registration of the Company’s common shares with the U.S. Securities and Exchange Commission (the “SEC”), the timing of the SEC’s review of the proposed application and any delays, including but not limited to delays related to COVID-19, and the Company’s strategic plans.

Although the Company believes that the material factors, expectations and assumptions expressed in such forward-looking statements are reasonable based on information available to it on the date such statements were made, no assurances can be given as to future results, levels of activity and achievements and such statements are not guarantees of future performance.

The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

THE CSE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.



EXFO solves video streaming problems for service providers

PR Newswire

Industry-first solution brings new revenue opportunities, reduces churn, and differentiates

QUEBEC CITY, Dec. 3, 2020 /PRNewswire/ – EXFO Inc. (NASDAQ: EXFO) (TSX: EXF), the communications industry’s test, monitoring and analytics experts, today launched Nova Active over-the-top (OTT) video monitoring, an industry-first solution allowing service providers to automatically detect and diagnose the root cause of video streaming problems as soon as they begin, and identify their origin—whether inside or outside of their networks. This is critical as video exceeds 65% of today’s network traffic, and will rise to over 90% in 5G networks by 2024.

OTT video streaming issues are the number one source of network-related customer churn


1


, a multimillion dollar problem for operators.2 In addition, consumers blame their video quality of experience (QoE) issues primarily on service providers,3 even though approximately half of all video quality issues originate outside of their networks and their control.4

As a result, service providers have high volumes of churn and are unable to effectively monetize OTT video services and leverage QoE as an essential differentiator. In turn, revenue losses and higher customer acquisition costs increase as the provider’s reputation suffers—even if the issues stem from a customer device, a poor home WiFi network or a content provider’s data center issue.

EXFO’s Nova Active OTT video monitoring solution now gives mobile network operators, internet service providers and content delivery providers the means to detect, segment, classify and diagnose the root cause of video streaming problems as soon as they begin. For the first time, service providers will be able to pinpoint whether problems like freezing, buffering or lagging come from their network, the video platform, the user’s device, or a video provider like YouTube or Netflix.

“As we all increasingly rely on video streaming for working, learning and socializing, the quality of over-the-top video services has never been more important. But until now, service providers did not have access to technology allowing them to quickly identify and solve video streaming problems, whether on mobile devices, at work or at home,” said Abdelkrim Benamar, EXFO’s Vice President of Service Assurance, Systems and Services. “EXFO’s unique solution will give service providers the ability to quickly pinpoint the source of these problems, resolve video quality issues for users and capture the growing opportunity that video represents.”

“Legacy video monitoring solutions are generally expensive, compute-intensive and tailored to content delivery applications. The industry needs real-time video monitoring that helps service providers overcome network issues, where the majority of issues originate,” said Gorkem Yigit, Lead analyst for the Cloud Infrastructure Strategies and Media Platforms research programs, Analysys Mason. “EXFO’s approach is designed to address this with an innovative approach that provides visibility into video quality, network performance and how they relate, so providers can optimize user experience with what’s within their control.”

Nova Active OTT video monitoring is an integral part of the Nova Active monitoring solution and the Nova Adaptive Service Assurance platform. Using a patent-pending approach that measures video streaming experience without compromising user privacy, operators can precisely identify, classify and localize issues as they occur. The new solution avoids big data analytics and decryption delays, allowing operations teams to prioritize and take immediate action.

Key benefits of the solution include:

  • Delivering end-to-end visibility of OTT services.
  • Supporting operators’ goals for 5G evolution.
  • Providing operators with the tools needed to manage the explosion in OTT video services.
  • Provides an extensible platform for keeping pace with ever evolving OTT services.
  • A 100% secure and private solution.
  • Monitoring video quality in near real time (per second VQS generation).

More information about the solution is available on EXFO.com.

About EXFO

EXFO (NASDAQ: EXFO) (TSX: EXF) develops smarter test, monitoring and analytics solutions for fixed and mobile network operators, webscale companies and equipment manufacturers in the global communications industry. Our customers count on us to deliver superior network performance, service reliability and subscriber insights. They count on our unique blend of equipment, software and services to accelerate digital transformations related to fiber, 4G/LTE and 5G deployments. They count on our expertise with automation, real-time troubleshooting and big data analytics, which are critical to their business performance. We’ve spent over 35 years earning this trust, and today 1,900 EXFO employees in over 25 countries work side by side with our customers in the lab, field, data center and beyond.

Blog:
https://bit.ly/39v5oH0 
Webinar: https://bit.ly/36p7ypE 

____________________


1

Ipsos 2019 survey, Sapio Research consumer survey, Nov-2020


2

Sapio Research consumer survey, Nov-2020, EXFO market analysis


3

Idem.


4

Source RCR / EXFO global video monitoring research, 2020-09.

 

Cision View original content:http://www.prnewswire.com/news-releases/exfo-solves-video-streaming-problems-for-service-providers-301185161.html

SOURCE EXFO Inc.